• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐万古霉素肠球菌感染的防治进展

Advances in prevention and treatment of vancomycin-resistant Enterococcus infection.

作者信息

Isenman Heather, Fisher Dale

机构信息

aDivision of Infectious Diseases, University Medicine Cluster, National University Hospital, Singapore bYong Loo Lin School of Medicine, National University of Singapore, Singapore.

出版信息

Curr Opin Infect Dis. 2016 Dec;29(6):577-582. doi: 10.1097/QCO.0000000000000311.

DOI:10.1097/QCO.0000000000000311
PMID:27584589
Abstract

PURPOSE OF REVIEW

This article reviews data, particularly from the last 2 years, addressing the prevention and treatment of vancomycin-resistant Enterococcus (VRE). We focus on infection control, particularly active screening, use of contact precautions as well as pharmacologic options for therapy. This is timely given the evolving priorities in efforts towards the prevention and treatment of multidrug-resistant organisms globally.

RECENT FINDINGS

Key findings include new data regarding the impact of contact precautions on the incidence of VRE colonization and bloodstream infection, new laboratory screening methods, and novel decolonization strategies and treatments.

SUMMARY

Additional and specific measures beyond standard precautions for infection prevention of VRE remain controversial. Horizontal measures such as chlorhexidine bathing appear beneficial, as are nontouch environmental cleaning methods. Treatment options for invasive disease have improved considerably in the last decade. Decolonization strategies require further research. Overall, the threat of VRE seems exaggerated.

摘要

综述目的

本文回顾相关数据,特别是过去两年的数据,涉及耐万古霉素肠球菌(VRE)的预防和治疗。我们重点关注感染控制,尤其是主动筛查、接触预防措施的使用以及治疗的药物选择。鉴于全球在预防和治疗多重耐药菌方面不断变化的优先事项,这一回顾很及时。

最新发现

主要发现包括关于接触预防措施对VRE定植和血流感染发生率影响的新数据、新的实验室筛查方法以及新的去定植策略和治疗方法。

总结

除了预防VRE感染的标准预防措施外,额外的具体措施仍存在争议。诸如洗必泰沐浴等横向措施似乎有益,非接触式环境清洁方法也是如此。在过去十年中,侵袭性疾病的治疗选择有了很大改善。去定植策略需要进一步研究。总体而言,VRE的威胁似乎被夸大了。

相似文献

1
Advances in prevention and treatment of vancomycin-resistant Enterococcus infection.耐万古霉素肠球菌感染的防治进展
Curr Opin Infect Dis. 2016 Dec;29(6):577-582. doi: 10.1097/QCO.0000000000000311.
2
Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections.耐万古霉素肠球菌感染管理的治疗和预防选择。
J Antimicrob Chemother. 2003 Jun;51 Suppl 3:iii23-30. doi: 10.1093/jac/dkg273.
3
Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.在地方流行环境中,与减少耐万古霉素肠球菌传播的感染控制措施相关的成本和节约情况。
Infect Control Hosp Epidemiol. 2001 Jul;22(7):437-42. doi: 10.1086/501931.
4
The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.定植患者发生耐万古霉素肠球菌血流感染的风险。
Am J Infect Control. 2008 Dec;36(10):S175.e5-8. doi: 10.1016/j.ajic.2008.10.010.
5
Vancomycin-resistant enterococci.耐万古霉素肠球菌。
Crit Care Clin. 2013 Oct;29(4):841-52. doi: 10.1016/j.ccc.2013.06.006.
6
Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).预防万古霉素耐药性传播的建议。医院感染控制实践咨询委员会(HICPAC)的建议。
MMWR Recomm Rep. 1995 Sep 22;44(RR-12):1-13.
7
[Vancomycin resistant Enterococci (VRE)].耐万古霉素肠球菌(VRE)
Nephrol Ther. 2009 Jun;5 Suppl 4:S261-4. doi: 10.1016/S1769-7255(09)74556-0.
8
Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures.耐万古霉素肠球菌。检测、流行病学及控制措施。
Infect Dis Clin North Am. 1997 Jun;11(2):367-84. doi: 10.1016/s0891-5520(05)70361-5.
9
Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada.在加拿大预防耐万古霉素肠球菌(VRE)的传播。
Can Commun Dis Rep. 1997 Dec;23 Suppl 8:i-iv, 1-16, i-iv, 1-19.
10
Treatment options for vancomycin-resistant enterococcal infections.耐万古霉素肠球菌感染的治疗选择。
Drugs. 2002;62(3):425-41. doi: 10.2165/00003495-200262030-00002.

引用本文的文献

1
Antimicrobial Activities and Mode of Flavonoid Actions.黄酮类化合物的抗菌活性及作用方式。
Antibiotics (Basel). 2023 Jan 20;12(2):225. doi: 10.3390/antibiotics12020225.
2
An orally administered drug prevents selection for antibiotic-resistant bacteria in the gut during daptomycin therapy.一种口服药物可防止在达托霉素治疗期间肠道中出现对抗生素耐药的细菌。
Evol Med Public Health. 2022 Aug 25;10(1):439-446. doi: 10.1093/emph/eoac035. eCollection 2022.
3
Factorial design and post-antibiotic sub-MIC effects of linezolid combined with fosfomycin against vancomycin-resistant enterococci.
利奈唑胺联合磷霉素对耐万古霉素肠球菌的析因设计及抗生素后亚抑菌浓度效应
Ann Transl Med. 2022 Feb;10(3):148. doi: 10.21037/atm-21-4595.
4
Evaluation of Quadruple Real-Time PCR Method to Detect Enterococci Carrying Vancomycin-Resistant Genes in Rectal Swabs.评估四重实时荧光定量PCR法检测直肠拭子中携带耐万古霉素基因肠球菌的效果
Front Med (Lausanne). 2020 Sep 8;7:403. doi: 10.3389/fmed.2020.00403. eCollection 2020.